ITeos Therapeutics (NASDAQ:ITOS) reported quarterly earnings of $1.82 per share. This is a 566.67 percent increase over losses of $(0.39) per share from the same period last year.
Costamare Raises $5M Via Institutional Equity Offering
On February 6, 2023, Cuentas Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”) for the